Next Article in Journal
Quantification of Carotid Intraplaque Hemorrhage: Comparison between Manual Segmentation and Semi-Automatic Segmentation on Magnetization-Prepared Rapid Acquisition with Gradient-Echo Sequences
Previous Article in Journal
Classification of Benign and Malignant Breast Tumors Using H-Scan Ultrasound Imaging
Previous Article in Special Issue
BRCA1/2 Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories
Open AccessArticle

Ovarian Cancer Targeting Phage for In Vivo Near-Infrared Optical Imaging

1
Department of Chemistry, Western Illinois University, 214 Currens Hall, Macomb, IL 61455, USA
2
Department of Biochemistry, University of Missouri, 117 Schweitzer Hall, Columbia, MO 65211, USA
3
Harry S. Truman Memorial Veterans Hospital, 1 Hospital Drive, Columbia, MO 65201, USA
*
Author to whom correspondence should be addressed.
Diagnostics 2019, 9(4), 183; https://doi.org/10.3390/diagnostics9040183
Received: 15 October 2019 / Revised: 4 November 2019 / Accepted: 8 November 2019 / Published: 10 November 2019
(This article belongs to the Special Issue Ovarian Cancer: Characteristics, Screening, Diagnosis and Treatment)
Ovarian cancer is often diagnosed at late stages due to current inadequate detection. Therefore, the development of new detection methods of ovarian cancer is needed. This may be achieved by phage nanoparticles that display targeting peptides for optical imaging. Here, two such phage clones are reported. Ovarian cancer binding and specificity of phage clones (pJ18, pJ24) and peptides (J18, J24) were investigated using fluorescent microscopy and modified ELISA. Further, AF680-labeled phage particles were subjected to biodistribution and optical imaging studies in SKOV-3 xenografted mice. Fluorescent microscopy and ELISA of phage and peptides showed significantly increased binding to SKOV-3 cells compared to controls. Additionally, these studies revealed that J18 exhibits specificity for ovarian cancer SKOV-3 and OVCAR-3 cell lines. Further, peptides displayed increased SKOV-3 binding compared to N35 (non-relevant peptide) with EC50 values of 22.2 ± 10.6 μM and 29.0 ± 6.9 (mean ± SE), respectively. Biodistribution studies of AF680-labeled phage particles showed tumor uptake after 4 h and excretion through the reticuloendothelial system. Importantly, SKOV-3 tumors were easily localized by optical imaging after 2 h and 4 h and displayed good tumor-to-background contrast. The fluorescent tumor signal intensity was significantly higher for pJ18 compared to wild type (WT) after 2 h. View Full-Text
Keywords: phage; imaging; ovarian cancer; molecular targeting; nanoparticles; peptides phage; imaging; ovarian cancer; molecular targeting; nanoparticles; peptides
Show Figures

Figure 1

MDPI and ACS Style

Asar, M.; Newton-Northup, J.; Deutscher, S.; Soendergaard, M. Ovarian Cancer Targeting Phage for In Vivo Near-Infrared Optical Imaging. Diagnostics 2019, 9, 183.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop